Human CXCL7/NAP-2 DuoSet ELISA | R&D Systems DY393 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

R&D Systems

product type :

ELISA/assay

product name :

Human CXCL7/NAP-2 DuoSet ELISA

catalog :

DY393

quantity :

1 Kit (for 15 Plates)

price :

850 USD

citations: 18

Reference
Lengvenytė A, Cognasse F, Hamzeh Cognasse H, S xe9 n xe8 que M, Strumila R, Oli xe9 E, et al. Baseline circulating biomarkers, their changes, and subsequent suicidal ideation and depression severity at 6 months: A prospective analysis in patients with mood disorders. Psychoneuroendocrinology. 2024;168:107119 pubmed publisher
Fyksen T, Seljeflot I, Vanberg P, Atar D, Halvorsen S. Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes. Thromb Res. 2024;238:60-66 pubmed publisher
Friebel J, Wegner M, Bl xf6 baum L, Schencke P, Jakobs K, Puccini M, et al. Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation. Int J Mol Sci. 2024;25: pubmed publisher
Lee G, Lee S, Chae J, Kim J, Kim J, Jeong H. Antarctic Krill Oil from Euphausia superba Ameliorates Carrageenan-Induced Thrombosis in a Mouse Model. Int J Mol Sci. 2023;24: pubmed publisher
Guerrero S, S xe1 nchez Tirado E, Ag xfc xed L, Gonz xe1 lez Cort xe9 s A, Y xe1 xf1 ez Sede xf1 o P, Pingarr xf3 n J. Development of an Electrochemical CCL5 Chemokine Immunoplatform for Rapid Diagnosis of Multiple Sclerosis. Biosensors (Basel). 2022;12: pubmed publisher
Schutte M, Kleemann R, Nota N, Wiepjes C, Snabel J, T sjoen G, et al. The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis. PLoS ONE. 2022;17:e0261312 pubmed publisher
Kloss L, Dollt C, Schledzewski K, Krewer A, Melchers S, Manta C, et al. ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12. Cell Death Dis. 2019;10:760 pubmed publisher
Barwari T, Eminaga S, Mayr U, Lu R, Armstrong P, Chan M, et al. Inhibition of profibrotic microRNA-21 affects platelets and their releasate. JCI Insight. 2018;3: pubmed publisher
Sabrkhany S, Kuijpers M, van Kuijk S, Sanders L, Pineda S, Olde Damink S, et al. A combination of platelet features allows detection of early-stage cancer. Eur J Cancer. 2017;80:5-13 pubmed publisher
van Bon L, Affandi A, Broen J, Christmann R, Marijnissen R, Stawski L, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370:433-43 pubmed publisher
Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D, et al. Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc Natl Acad Sci U S A. 2011;108:8809-14 pubmed publisher
Landrø L, Ueland T, Otterdal K, Frøland S, Aukrust P. Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy. J Thromb Haemost. 2011;9:1075-7 pubmed publisher
de Mast Q, de Groot P, van Heerde W, Roestenberg M, van Velzen J, Verbruggen B, et al. Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy. Br J Haematol. 2010;151:495-503 pubmed publisher
Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher
Eagan T, Ueland T, Wagner P, Hardie J, Mollnes T, Damas J, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010;35:540-8 pubmed publisher
Yee J, Sadar M, Sin D, Kuzyk M, Xing L, Kondra J, et al. Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol. 2009;27:2787-92 pubmed publisher
Smith C, Damås J, Otterdal K, Øie E, Sandberg W, Yndestad A, et al. Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. J Am Coll Cardiol. 2006;48:1591-9 pubmed
Maheshwari A, Christensen R, Calhoun D. ELR+ CXC chemokines in human milk. Cytokine. 2003;24:91-102 pubmed

product information

master code :

DY393

SKU :

DY393

product name :

Human CXCL7/NAP-2 DuoSet ELISA

unit size :

1 Kit (for 15 Plates)

description :

The Human CXCL7/NAP-2 DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human CXCL7/NAP-2.

target :

CXCL7/NAP-2

category :

ELISAs

species :

Human

gene symbol :

PPBP

kit type :

Solid Phase Sandwich ELISA

elisaRange :

15.60 - 1000 pg/mL

top caption :

Human CXCL7/ NAP-2 ELISA Standard Curve

applications :

ELISA

USD :

850 USD

alt names :

Beta-TG, connective tissue-activating peptide III, CTAP III, CTAP3CTAP-III, CTAPIII, CXC chemokine ligand 7, C-X-C motif chemokine 7, CXCL7b-TG1, LA-PF4, LDGFTC1, Leukocyte-derived growth factor, low-affinity platelet factor IV, Macrophage-derived growth factor, MDGFTC2, NAP2, NAP-2, NAP-2-L1, neutrophil-activating peptide 2, neutrophil-activating peptide-2, PBPTHBGB, platelet basic protein, PPBP, pro-platelet basic protein (chemokine (C-X-C motif) ligand 7), SCAR10, SCYB7beta-thromboglobulin, small inducible cytokine B7, small inducible cytokine subfamily B, member 7, Small-inducible cytokine B7, TGB, TGB1B-TG1, THBGB1, thrombocidin 1, thrombocidin 2, thromboglobulin, beta-1

storage :

Store the unopened product at 2 - 8 ░C. Do not use past expiration date.